7r3i
From Proteopedia
(Difference between revisions)
| (One intermediate revision not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==PROSS optimitzed variant of RhlR (61 mutations) in complex with the synthetic antagonist mBTL== | |
| - | + | <StructureSection load='7r3i' size='340' side='right'caption='[[7r3i]], [[Resolution|resolution]] 3.10Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[7r3i]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Pseudomonas_aeruginosa_PAO1 Pseudomonas aeruginosa PAO1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7R3I OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7R3I FirstGlance]. <br> | |
| - | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.1Å</td></tr> | |
| - | [[Category: | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=K5G:4-(3-bromophenoxy)-N-[(3S)-2-oxothiolan-3-yl]butanamide'>K5G</scene></td></tr> |
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7r3i FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7r3i OCA], [https://pdbe.org/7r3i PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7r3i RCSB], [https://www.ebi.ac.uk/pdbsum/7r3i PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7r3i ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Pseudomonas aeruginosa PAO1]] | ||
| + | [[Category: Blankenfeldt W]] | ||
| + | [[Category: Henke S]] | ||
Current revision
PROSS optimitzed variant of RhlR (61 mutations) in complex with the synthetic antagonist mBTL
| |||||||||||
